SCHEMBL20365993

SCHEMBL20365993

CCSc1ncc(CO)c(NC2CCCC2)n1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.38
▸ GABBR2 O75899 4/20 0.36
▸ GABBR1 Q9UBS5 4/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ SLC29A1 Q99808 2/20 0.35
▸ ADORA3 P0DMS8 1/20 0.34
▸ AXL P30530 1/20 0.34
▸ MERTK Q12866 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ TLR8 Q9NR97 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2622288 0.86 GABBR2 (0.47) KMT2AGABBR2GABBR1MEN1CYP1A2
SCHEMBL4713140 0.85 GABBR2 (0.46) KMT2AGABBR2GABBR1MEN1CYP1A2
SCHEMBL4711841 0.85 GABBR2 (0.46) KMT2AGABBR2GABBR1MEN1CYP1A2
SCHEMBL22860693 0.84 MERTK (0.46) KMT2AGABBR2GABBR1MEN1CYP1A2
SCHEMBL4715006 0.81 MERTK (0.50) KMT2AGABBR2GABBR1MEN1CYP1A2
SCHEMBL20365996 0.80 NR2F2 (0.45) KMT2AMEN1KDM4EAXLMERTK
SCHEMBL6424706 0.79 KMT2A (0.60) KMT2AMEN1CYP1A2KDM4EHSD17B10
SCHEMBL22184593 0.77 KMT2A (0.51) KMT2AGABBR2GABBR1MEN1CYP1A2
SCHEMBL6944320 0.76 KMT2A (0.45) KMT2AGABBR2GABBR1MEN1CYP1A2
SCHEMBL29507825 0.76 MERTK (0.46) KMT2AGABBR2GABBR1MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3718560-A2 CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE The University of North Carolina at Chapel Hill (US) 2020-10-07 — — EP disclosed
EP-3406260-B1 CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE UNIV NORTH CAROLINA CHAPEL HILL (US) 2020-09-23 — — EP disclosed
EP-3025724-B1 CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE UNIV NORTH CAROLINA CHAPEL HILL (US) 2018-07-11 — — EP disclosed
Send feedback